Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS
Cancers · 06.03.2026 · 18 (5) · 847
DOI: 10.3390/cancers18050847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 06.03.2026. Verfasst von Daniel Christoph Amberger und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospital of Munich and the University Hospital of Augsburg.
Abstract (Originalsprache)
Background/Objectives: Acute myeloid leukemia (AML) is characterized by impaired anti-leukemic immune responses, and the ex vivo or in vivo generation of dendritic cells (DCs), including leukemic dendritic cells (DCleu), represents a promising strategy to stimulate immune cells and improve anti-leukemic activity.
Methods
This study examined the generation, phenotype and functional relevance of DCs and DCleu produced ex vivo from blast-containing PBMNCs and whole blood (WB) in AML. Using both standard DC/DCleu-generating protocols and available Kits.
Results
We show that DC/DCleu can be reliably generated with both methods. Generated DC/DCleu effectively activated T cells during mixed lymphocyte cultures (MLCs), resulting in enhanced anti-leukemic cytotoxicity. Improved blast lysis correlated with specific immunological features, including higher frequencies of generated DCleu and mature DC subsets, as well as a certain cytokine pattern after DC/DCleu cultures or MLC. In addition, the frequencies of proliferating T cells after MLC strongly correlated with the degree of achieved blast lysis, underscoring the importance of efficient DC/DCleu-mediated T cell stimulation. Both the frequencies of generated DC/DCleu and the resulting blast lytic activity were linked to overall survival (OS) in AML patients. Individuals who failed to demonstrate improved blast lysis exhibited significantly reduced OS, suggesting inadequate immune responsiveness of patients in vivo.
Conclusions
These findings identify phenotypic and functional immune parameters as predictors of clinical outcome and highlight the prognostic relevance of ex vivo immune profiling. This approach may help to optimize and personalize future immunotherapeutic strategies in AML.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.
- First Department of Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.
- Bavarian Cancer Research Center (BZKF), 80539 Munich, Germany.
- Department of Haematology and Oncology, University Hospital of Augsburg, 86156 Augsburg, Germany.
ORCID-Profile: Daniel Christoph Amberger, Lara Kristina Klauer
Förderung
- University Hospital of Munich and the University Hospital of Augsburg
Zitieren
APA
Amberger, D. C., Fischer, Z., Deen, D., Hirn-Lopez, A., Plett, C., Rabe, A., Schwepcke, C., Ugur, S., Klauer, L. K., Ansprenger, C., Liepert, A., Freudenreich, M., Schmid, C., & Schmetzer, H. M. (2026). Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS. Cancers, 18(5), 847. https://doi.org/10.3390/cancers18050847
Vancouver
Amberger DC, Fischer Z, Deen D, Hirn-Lopez A, Plett C, Rabe A, et al. Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS. Cancers. 2026;18(5):847. doi:10.3390/cancers18050847
BibTeX
@article{Amberger2026,
author = {Amberger, Daniel Christoph and Fischer, Zuzana and Deen, Diana and Hirn-Lopez, Anika and Plett, Caroline and Rabe, Alexander and Schwepcke, Christoph and Ugur, Selda and Klauer, Lara Kristina and Ansprenger, Christian and Liepert, Anja and Freudenreich, Markus and Schmid, Christoph and Schmetzer, Helga Maria},
title = {Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS},
journal = {Cancers},
year = {2026},
volume = {18},
number = {5},
pages = {847},
doi = {10.3390/cancers18050847}
}
EUVIMED